Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial

NCT04339816 is registered in ClinicalTrials.gov with Frantisek Duska, MD, PhD as lead sponsor.

NCT NCT04339816
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04339816 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycin Added to Hydrochloroquine in Patients Admitted to Intensive Care Due to Coronavirus Disease 2019 (COVID-19)- Randomised Controlled Trial
Lead sponsor
Frantisek Duska, MD, PhD
Phase
Phase 3
Overall status
Terminated
Start date
May 13, 2020
Completion date
November 4, 2020
Enrollment
3 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, respiratory failure